Controlled Recordkeeping - Mpje

1. A DEA investigator comparing a pharmacy's Schedule II dispensing records with corresponding prescriptions finds that 15 dispensing log entries have no corresponding prescriptions on file, and 8 prescriptions on file have no corresponding dispensing log entries. Which of the following best analyzes the significance of this finding?
   Answer: Both discrepancies suggest potential recordkeeping violations or diversion and must be thoroughly investigated to ensure compliance with DEA regulations. Both types of discrepancy raise serious concerns. Dispensing log entries without corresponding prescriptions may indicate controlled substances were dispensed without valid prescriptions -- a significant violation. Prescriptions without dispensing log entries may reflect data entry omissions or could signal misappropriation. Both must be thoroughly investigated. A is incorrect because Schedule II records must be exact and any discrepancy requires investigation. B is incorrect because dispensing log entries without prescriptions are actually the more serious diversion concern, but both categories require investigation. D is incorrect because there is no percentage threshold normalizing controlled substance record discrepancies.
2. A pharmacy uses DEA filing Option 3, maintaining all prescriptions in a single chronological file. What must be done to each Schedule III and IV prescription filed in this combined system?
   Answer: Each Schedule III and IV prescription must be marked with a red C at least 1 inch in height on its face before filing, making it readily identifiable within the combined file. Under DEA filing Option 3, Schedule III through V prescriptions filed in a combined file must be marked with a red C no less than 1 inch in height on the face of the prescription. This allows controlled substance prescriptions to be readily identified and separated for DEA inspection. A is incorrect because stamping the schedule number is not the DEA standard; the red C is specified. B is incorrect because colored folders are not the DEA marking standard. D is incorrect because an electronic cross-reference does not satisfy the physical red C marking requirement for paper prescriptions under Option 3.
3. When a pharmacy receives a shipment of Schedule II controlled substances, which information must be documented in the receiving record?
   Answer: The date of receipt, drug details, supplier's DEA number, and pharmacy's DEA number recorded on DEA Form 222 Copy 3. When Schedule II controlled substances are received, the pharmacy must complete the receiving portion of DEA Form 222 Copy 3 with the required information: date of receipt, supplier name and address, supplier DEA number, drug name, dosage form, strength, and quantity received. A is incorrect because drug name and quantity alone are insufficient; supplier identity and DEA number are also required. B is incorrect because cost of shipment is not a required DEA element. C is incorrect because the staff member's name is not the primary regulatory element required.
4. What information must be included in a controlled substance dispensing record for a Schedule II prescription?
   Answer: Patient and prescriber details, DEA number, drug specifics, dispensing date, directions, and pharmacist identity. A complete Schedule II dispensing record must contain: patient name and address, prescriber name and address including DEA registration number, date of dispensing, drug name, strength, dosage form, quantity dispensed, directions for use, and identification of the dispensing pharmacist. A is incorrect because three fields are far insufficient for a complete Schedule II dispensing record. B is incorrect because quantity and date are core required elements that must appear in the same record. C is incorrect because insurance and billing information are not DEA-required elements of the dispensing record.
5. DEA regulations require certain controlled substance records to be readily retrievable upon request. Which of the following most accurately defines this standard?
   Answer: Readily retrievable means records can be quickly separated from others and produced promptly for DEA inspection upon request. Under 21 CFR 1304.02(c), records are considered readily retrievable when they are maintained so that they can be separated out from all other records in a reasonable time -- whether by asterisking, redlining, or equivalent visual identification in a manual system, or by separation capability in an electronic system -- and produced for inspection. The regulation does not establish a universal two-business-day rule or enumerate specific categories requiring immediate availability by name; the standard is prompt separability and availability upon DEA request. A is incorrect because a universal 24-hour production deadline is not the stated regulatory standard. C is incorrect because electronic records are explicitly accommodated by the readily retrievable definition as long as they can be separated out in a reasonable time. D is incorrect because a specific front-office location is not the regulatory standard; accessibility upon request is.
6. A PIC grants a power of attorney (POA) to a staff pharmacist authorizing that pharmacist to sign DEA Form 222 for ordering Schedule II controlled substances. What are the recordkeeping obligations related to this POA?
   Answer: The POA must be written, signed by the registrant and attorney-in-fact, and kept on file at the pharmacy. A DEA power of attorney for signing DEA Form 222 must meet the execution requirements of 21 CFR 1305.05: it must be in writing and signed by the registrant or a partner or officer of the registrant, the attorney-in-fact, and two witnesses. The executed POA must be maintained at the pharmacy as part of the controlled substance records. When the authorization is revoked, the revocation must also be documented and retained with the POA. A is incorrect because oral notification to the DEA is not the required mechanism; written execution and on-site retention are required. C is incorrect because DEA POAs are not registered in a DEA central database; they are maintained at the pharmacy. D is incorrect because oral grants do not satisfy DEA requirements; written execution with the required signatures is mandatory.
7. A pharmacy is permanently closing and surrendering its DEA registration. What must happen to the controlled substance records?
   Answer: Records must be kept for two years after creation, accessible to the DEA. When a pharmacy closes, DEA records must still be retained for the full two-year period from each record's creation date. The closing pharmacy must arrange for continued record accessibility -- whether by retaining them personally or through a successor entity. B is incorrect because closing the pharmacy does not authorize immediate record destruction; the two-year retention obligation continues. C is incorrect because DEA records are not transferred to the DEA regional office upon closure. D is incorrect because transferring records to a nearby pharmacy is not the correct mechanism.
8. A pharmacy chain uses a centralized server storing controlled substance dispensing records for all five locations. During a DEA inspection of Location 3, the investigator requests records that are only accessible from Location 1's dispensing computer. Which of the following best analyzes whether this system satisfies DEA readily retrievable requirements?
   Answer: The system fails requirements if Location 3 cannot independently access its own records without relying on another location. Each DEA registration is location-specific and the registered location must have its records readily retrievable at that address. A centralized system requiring access through another location's system to retrieve one location's records may not satisfy the per-location readily retrievable requirement. A is incorrect because technical accessibility from any location is not the same as having records readily retrievable at the specific registered location. C is incorrect because chain pharmacies have separate DEA registrations with independent recordkeeping obligations. D is incorrect because a 48-hour IT-dependent retrieval may not satisfy the standard, particularly for records that must be immediately available.
9. Under federal DEA regulations, what recordkeeping is required when a pharmacy sells Schedule V controlled substances without a prescription where permitted by state law?
   Answer: Record each sale in a bound book with purchaser details, sale date, drug name and quantity, and pharmacist's signature or initials. Under 21 CFR 1306.26, Schedule V controlled substances dispensed without a prescription must be documented in a bound record book with: purchaser name and address, date of sale, name and quantity of the Schedule V product, and the dispensing pharmacist's signature or initials. Quantity limits also apply. A is incorrect because Schedule V OTC sales do have federal recordkeeping requirements. B is incorrect because DEA Form 222 is for ordering Schedule I and II substances, not for documenting OTC sales. C is incorrect because PDMP entry is a state-law requirement separate from the federal Schedule V OTC sales log.
10. A controlled substance dispensing record was created exactly two years ago today. Must it still be retained as of today?
    Answer: Yes, the record must be retained today as the two-year retention period expires at the end of today. The two-year retention period runs from the date the record was created. On the exact date that is two years from the creation date, the retention period expires -- meaning the record is still required today but may become eligible for disposal after today. B is incorrect because the two-year period is a precise legal requirement, not an approximate one. C is incorrect because dispensing records have the same two-year minimum as other controlled substance records; there is no 18-month tier. D is incorrect because no additional six-month buffer beyond the two-year minimum is required by DEA regulations.
11. A pharmacist transfers a paper Schedule III controlled substance prescription from one pharmacy to another for refill purposes. What recordkeeping obligations apply to both the transferring and receiving pharmacies?
    Answer: Both pharmacies must document the transfer details, including dates and pharmacist identities, and adhere to refill limits. When a paper Schedule III prescription is transferred for refill purposes, the transferring pharmacy must annotate the original prescription with the transfer date, the transferring pharmacist's identity, and the receiving pharmacy's information. The receiving pharmacy must document the receipt and may not dispense beyond the original authorized number of refills. Note that electronic controlled substance prescriptions are subject to different transfer requirements under 21 CFR Part 1311, which permits a one-time transfer of an electronic prescription for initial filling. A is incorrect because both pharmacies have documentation obligations for the transfer. B is incorrect because the transferring pharmacy must annotate the original prescription as described. D is incorrect because DEA Form 222 applies to Schedule I and II ordering, not Schedule III prescription transfers; DEA pre-approval is not required.
12. During a DEA audit, an investigator discovers that a pharmacy's Schedule II dispensing records show multiple instances where the quantity dispensed column has been whited out and a different lower quantity written in. The pharmacist explains these were corrections using correction fluid. Which of the following best analyzes the significance of this finding?
    Answer: Using correction fluid on controlled substance records is prohibited and may lead to legal consequences. Obliterating original entries in controlled substance records through correction fluid is a serious DEA violation. Original entries must remain legible and any correction must be made by single-line strikethrough with annotation. Hiding original entries may constitute falsification of federal records, which can carry criminal penalties. A is incorrect because initialing a whited-out correction does not remediate the underlying obliteration of the original entry. B is incorrect because this is not a minor concern; obliteration of controlled substance records is a substantive violation. C is incorrect because the general utility of correction fluid does not make it acceptable for altering federal controlled substance records.
13. During a DEA inspection, the investigator requests Schedule II dispensing records from the past 22 months. The pharmacy produces records from the past 18 months but states records from months 19 through 22 ago were destroyed in a water leak with no backup copies. Which of the following best analyzes the compliance concern?
    Answer: The pharmacy is non-compliant; records must be maintained for two years, regardless of circumstances like water damage. DEA records must be maintained for two years. Records from 19 to 22 months ago fall within the retention period and must be available. Destruction by water damage does not discharge the retention obligation, though it may be a mitigating factor in enforcement. The pharmacy must notify the DEA, document the incident, and implement corrective measures. A is incorrect because force majeure does not exempt a registrant from DEA recordkeeping obligations. C is incorrect because partial compliance does not satisfy the full requirement. D is incorrect because an insurance claim does not satisfy the DEA retention obligation.
14. A state law requires pharmacies to maintain controlled substance dispensing records in a specific format that differs from the DEA format. A pharmacist wants to use the state format to satisfy both requirements simultaneously. Which of the following best analyzes whether the state format can satisfy federal DEA requirements?
    Answer: The state format satisfies federal requirements if it includes all DEA-required information. A single record can satisfy both state and federal requirements if it captures all information required by each. If the state format is more detailed than federal requirements, it likely satisfies both. If it omits DEA-required elements, the pharmacy must supplement. The more stringent standard governs. A is incorrect because state boards are not the primary regulators of federal DEA recordkeeping requirements. B is incorrect because DEA does not require case-by-case approval of state record formats. C is incorrect as an absolute statement; a well-designed state format may capture all federally required elements.
15. A pharmacy uses DEA filing Option 3, in which all prescriptions are kept in a single combined file. How must Schedule II controlled substance prescriptions be handled under this filing system?
    Answer: Schedule II prescriptions must be filed separately or be readily retrievable, unlike Schedule III-V which can be marked with a red C. Even under filing Option 3, Schedule II prescriptions must still be maintained separately or be readily retrievable. The one-file-with-red-C flexibility applies only to Schedule III through V prescriptions. A is incorrect because physical location behind the counter is not the applicable standard. B is incorrect because electronic retrievability alone does not satisfy the Schedule II requirement under Option 3. C is incorrect because the red C requirement applies only to Schedule III-V; Schedule II prescriptions retain their separate filing requirement.
16. A pharmacist discovers that a controlled substance dispensing record from three days ago incorrectly shows 30 tablets dispensed when the patient actually received 60 tablets. How should this error be corrected?
    Answer: Draw a line through the error, write the correct amount, and initial and date the correction. Controlled substance dispensing records must not be altered in a way that obliterates the original entry. The proper correction method is to draw a single line through the error keeping it legible, write the correct information, and initial and date the correction. A is incorrect because erasing or overwriting the original entry is falsification of a controlled substance record. C is incorrect because a corrected dispensing record annotation is the appropriate mechanism; writing a new prescription is not the correct approach. D is incorrect because DEA authorization is not required to correct a documentation error using the proper annotation method.
17. A pharmacy uses DEA Form 222 to order Schedule II controlled substances. How must Copy 3 of each executed Form 222 be maintained?
    Answer: Copy 3 must be maintained at the registered location and retained for at least two years; DEA executed order forms must be kept separately from other records and be readily retrievable. The pharmacy must retain Copy 3 of each executed DEA Form 222 at the registered location for at least two years, separately from other records and readily retrievable. Copy 3 documents both the order placed and receipt confirmation. B is incorrect because Copy 3 is not discarded after receipt; it is the pharmacy's permanent order record. C is incorrect because Copy 3 is retained by the pharmacy, not sent to the DEA. D is incorrect because the two-year retention requirement applies to order forms just as it applies to other controlled substance records.
18. A pharmacist partially fills a Schedule II prescription for a patient in a long-term care facility (LTCF). Under DEA recordkeeping requirements, which of the following must be documented for the partial fill?
    Answer: Document the date, quantity dispensed, quantity remaining, and pharmacist's identity on the prescription for each partial fill. Schedule II partial fills for LTCF and terminally ill patients are permitted and must be documented on the prescription: date dispensed, quantity dispensed, quantity remaining, and dispensing pharmacist identity. Subsequent partial fills must similarly be documented, and the prescription cannot be filled beyond 60 days from its issue date. A is incorrect because partial fills have specific additional documentation requirements. B is incorrect because Schedule II partial fills are specifically permitted for LTCF patients. D is incorrect because DEA Form 222 is for ordering Schedule I and II substances, not for documenting dispensing.
19. A hospital pharmacy provides controlled substances to nursing units and documents each transaction in an electronic medication administration record system. Which of the following best describes the hospital pharmacy's DEA controlled substance recordkeeping obligations?
    Answer: Hospital pharmacies must maintain complete controlled substance records for DEA inspection, retained for at least two years. Hospital pharmacies are subject to the same DEA recordkeeping requirements as retail pharmacies. Complete records of all controlled substance transactions must be maintained for at least two years and be available for DEA inspection. B is incorrect because hospital formulary status does not exempt a pharmacy from DEA recordkeeping. C is incorrect because the two-year recordkeeping requirement applies to all schedules; Schedule III-V hospital transactions are not exempt. D is incorrect because Joint Commission accreditation is a quality credential, not a DEA compliance equivalent.
20. A pharmacy uses an electronic dispensing system to record all controlled substance transactions. What requirements must the electronic system meet to satisfy DEA controlled substance recordkeeping obligations?
    Answer: Electronic records must ensure integrity, prevent alterations, provide an audit trail, and allow retrieval and printing for DEA inspection. DEA regulations permit electronic recordkeeping for controlled substances if the system maintains record integrity, prevents unauthorized alterations, provides an audit trail for any changes, and allows records to be separated and produced for inspection within the readily retrievable standard. A is incorrect because DEA regulations explicitly permit qualifying electronic records. B is incorrect because electronic records are acceptable for all schedules; the distinction between CII and CIII-V does not affect acceptability of electronic systems. D is incorrect because DEA does not maintain a list of approved vendors; the system must meet the regulatory standards.

Start this quiz